AzTrials
AzTrials

Evaluating NIAAA's Alcohol ScreenerNCT02106754

Alcohol Screening & Brief Lntervention in Juvenile Justice: Filling the Gap

A study testing Brief Intervention, Brief Intervention with Coaching and Treatment as Usual in people with Evaluating NIAAA's Alcohol Screener and Evaluating a Brief Intervention, run by University of Rhode Island at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This proposal is in response to RFA-AA-12-008, Evaluation of NIAAA's Alcohol Screening Guide for Children and Adolescents. Of particular interest to the agency are evaluation of the Screener in clinical and/or other settings to predict alcohol-related consequences including use disorder; its use as an initial screen… Read more about this study

Who is it for?
Ages 9 to 18 yearsHealthy volunteers can take part
What is being tested?
Brief Intervention, Brief Intervention with Coaching and Treatment as Usual
Could I receive a placebo?
No, everyone receives an active treatment
How many people
576 participants
Where
1 siteUnited States
Study dates
Sep 2012to 31 May 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 9 to 18 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • Youths 9-18 years old

Who cannot join

  • Age (< 9, >18 years)
  • Prior enrollment in a behavioral intervention study
  • PO previously engaging them with Screener

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Rhode Island

    Kingston, Rhode Island, 02881

Other trials in United States

About this study

This proposal is in response to RFA-AA-12-008, Evaluation of NIAAA's Alcohol Screening Guide for Children and Adolescents. Of particular interest to the agency are evaluation of the Screener in clinical and/or other settings to predict alcohol-related consequences including use disorder; its use as an initial screen for drug use, cigarette smoking, conduct disorder, and unprotected sex; and its performance in making predictions concurrently and prospectively. This proposal targets these areas of interest. In addition, the investigators will study implementation of the Brief Intervention (BI) associated with the Screener. There is a great need for both screening and BI in juvenile probation settings as many of these youths have great need but are underserved.Many probation departments are turning to BI to work with probationers and parolees. Screening and BI has demonstrated efficacy in these settings, and yet no randomized control trials have been conducted to evaluate effectiveness in juvenile probation settings. Probation Officers (POs; n=40) are randomized to Screener (S), Screener+BI (SBI), or coaching (CSBI). Youths (N=1000) are randomized to 1 of these 3 conditions, and all receive usual services (US). US consist of regular check-in with PO and access to referral services as needed (counseling, academic tutoring, etc.). Research staffers conduct in-depth assessment at baseline, 6- and 12- months. Sensitivity, specificity, and positive and negative predictive powers (SN, SP, PP, NP) are calculated to predict alcohol risk and consequences, as well as other risky behaviors concurrently and prospectively across age-groups. A 1-way design (S vs SBI vs CSBI) will be used to determine whether SBI and CSBI enhance youth services-use and reduce risks (e.g., alcohol use, risky sex). We examine moderators of outcomes (youth age, PO characteristics) and whether coaching (an important consideration in implementation science) in use of BI improves outcomes. This study will be the first randomized controlled trial evaluating the effectiveness of SBI in a juvenile probation setting.

Read the detailed description
  1. A) To evaluate SN, SP, PP and NP of the 2-question Alcohol Screener to detect: a) alcohol problems (academic, social, injuries, intoxicated driving, unprotected sex), b) abuse/dependence, c) past 4 week binge drinking. 1B) This will be repeated to predict risk prospectively over 12 months. Classification rates will be compared for race, ethnicity, gender, and age groups.
  2. A) To evaluate SN, SP, PP and NP of the 2-question Screener to detect a) 30-day drug use, b) 30-day cigarette use, c) conduct disorder, d) unprotected sex. 2B) This will be repeated to predict risk prospectively over 12 months. Classification rates will be compared for race, ethnicity, gender, and age groups. 3) To evaluate BI as compared to usual procedures. The investigators hypothesize those youths in BI will a) receive more services, b) be more satisfied with services, c) rate the relationship with the PO more highly, and d) have improved outcomes (alcohol, alcohol-related problems, problem recognition).
Being tested
Brief Intervention, Brief Intervention with Coaching, Treatment as Usual

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Brief InterventionBehavioural

  • Brief Intervention with CoachingBehavioural

  • Treatment as UsualBehavioural

Study groups in NCT02106754
Study groupRoleWhat they receive
Brief InterventionExperimentalYouth may receive brief intervention from their provider based on randomization.
Receives: Behavioral: Brief Intervention
Treatment As UsualActive comparatorYouth may receive treatment as usual from their provider based on randomization.
Receives: Behavioral: Treatment as Usual
Brief Intervention with CoachingExperimentalYouth may receive brief intervention with coaching from their provider based on randomization.
Receives: Behavioral: Brief Intervention with Coaching

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Measure of change across three points in time for alcohol, cigarette and other drug use

    Time-Line Follow-Back (TLFB) measures past 30-day use of alcohol, cigarettes, and other drugs at each assessment (BL, 6- \& 12-month). It is well known, reliable and valid (Harrison \& McKee, 2008; Carey et al, 2004). Days/month used, and binge-drinking are obtained. For analyses involving classification rates, binge >

    1 is considered problematic, and definitions of binge will follow Donovan (2009).

    RCQ (Risks/Consequences Questionnaire; Stein et al, 2010) provides an overall

    Measured: baseline, 6 month follow-up, 12 month follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Apr 2014 (estimated)
  2. Study startSep 2012
  3. Primary completion31 May 2019
  4. Study completion31 May 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Single group
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
576 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02106754
Sponsor's protocol ID
R01AA021855
Status last verified
Oct 2019
First submitted
27 Mar 2014
Last updated
10 Oct 2019
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Brief Intervention, Brief Intervention with Coaching and Treatment as Usual in people with Evaluating NIAAA's Alcohol Screener and Evaluating a Brief Intervention, run by University of Rhode Island at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Oct 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Measure of change across three points in time for alcohol, cigarette and other drug use (time frame: baseline, 6 month follow-up, 12 month follow-up). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Oct 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in